Medexus Pharmaceuticals Inc. (TSX:MDP)

Canada flag Canada · Delayed Price · Currency is CAD
2.760
-0.080 (-2.82%)
Jan 20, 2026, 3:59 PM EST
-35.81%
Market Cap90.90M
Revenue (ttm)145.00M
Net Income (ttm)530.69K
Shares Out32.46M
EPS (ttm)0.02
PE Ratio156.74
Forward PE10.81
Dividendn/a
Ex-Dividend Daten/a
Volume54,766
Average Volume45,728
Open2.800
Previous Close2.840
Day's Range2.710 - 2.840
52-Week Range1.960 - 5.560
Beta1.89
RSI50.57
Earnings DateFeb 11, 2026

About Medexus Pharmaceuticals

Medexus Pharmaceuticals Inc. operates as a pharmaceutical company in Canada and the United States. The company focuses on various therapeutic areas comprising allergy, dermatology, hematology, oncology, rheumatology, and rare diseases. Its primary products include IXINITY, an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B; Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; Rupall, a prescription allergy medication; GRAFAPEX, an injection ... [Read more]

Sector Healthcare
Founded 2000
Employees 91
Stock Exchange Toronto Stock Exchange
Ticker Symbol MDP
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.